Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
nCino Introduces Integration Gateway to Streamline Data Connectivity for Financial Institutions and Fintech Partners
-
Dime Continues to Execute on Growth Plan With Commercial Lending Expansion
-
Eyenuk Secures World’s First National Health System Deployment of Autonomous AI Eye Screening Technology
-
QNB Group, Standard Chartered and DMZ Finance Launch Dubai International Financial Centre’s First Tokenized Money Market Fund
-
Arch Strengthens its Position as a Leading Kidney Therapeutics Company with the Acquisition of a Breakthrough Platform to Develop New Drugs Targeting Chronic Kidney Disease (CKD)
-
WISDOMTREE MULTI ASSET ISSUER PUBLIC LIMITED COMPANY (a public company incorporated with limited liability in Ireland) WISDOMTREE S&P 500 3X Daily Short SECURITIES ISIN: IE00B8K7KM88
-
Brooge Energy Limited Announces Extraordinary Meeting of Shareholders
-
Man Group PLC : Form 8.3 - American Axle & Manufacturing Holdings, Inc.
-
Man Group PLC : Form 8.3 - Spectris plc
-
Guelph Council Unanimously Endorses Resonance Client Fusion Homes’ Vision for the Guelph Innovation District
-
Twin Token Framework From XRP Tundra Introduces New Yield Opportunities for XRP Holders
-
Savitri Network Officially Launches and Opens Private Sale on September 15, 2025
-
EyeMD EMR Healthcare Systems Announces Rebrand to Optivate, Signaling Expanded Vision for Ophthalmology Practices and Eye Care Providers
-
Canadians Called to Vote as Fashion Meets Compassion at the 2025 Cashmere Collection
-
The Distillery Winter Village Returns November 13
-
Microbix Client Labquality Introduces Novel EQA Scheme at ESCV
-
Invivyd Announces Appointment of Kristie Kuhl as Chief Communications Officer
-
Anfield Receives Approval to List on NASDAQ
-
Nevada Lithium Announces Significant Amounts of Critical Minerals Rubidium and Cesium Within its Bonnie Claire Lithium Project
-
Carlton Precious Announces Filing of Notice of Intention to Sell Athena Gold Corporation Common Shares
-
Tonix Pharmaceuticals Announces In-licensing Phase 2/3-Ready Monoclonal Antibody Designed for Seasonal Prevention of Lyme Disease (TNX-4800)
-
Lithium Ionic Announces Definitive Feasibility Study Results for Bandeira Lithium Project, Minas Gerais, Brazil
-
Wrap Enters U.S. Army xTechCounter Strike C-UAS Competition with Project MERLIN Innovation
-
Signaling Shift in Innovation Landscape, Tilt Introduces New HR Category: Leave Experience Management
-
Snow melts earlier in burned forests, new Science Advances study finds
-
Sight Sciences Announces Publication of a Systematic Literature Review and Meta-Analysis Showing OMNI® Surgical System Achieves Clinically Significant, Long-Term Reductions in IOP and Medication Use
-
Kymera Therapeutics Announces Late-Breaking Oral Presentations on KT-621, a First-In-Class, Oral STAT6 Degrader, at the European Academy of Dermatology & Venereology and European Respiratory Socie
-
Nurix Therapeutics Presents Preclinical Data from Novel IRAK4 Degrader, GS-6791, Demonstrating Potent Inhibition of IL-1 and IL-36 in Vitro and Efficacy in a Model of Dermatitis
-
TRUE-See Announces Strategic Partnership with Dr. Peter Chang and the Center for Applied AI Research at the University of California, Irvine
-
Broken Coast Cannabis Brand Launches Premium and Limited BC Selects Line and Unveils New Strain “Sprits 26”, Elevates Craft Portfolio with Modern Blue Dream Release
-
Regeneron Announces Positive Phase 3 Trial in Adults with Ultra-Rare Genetic Disorder Fibrodysplasia Ossificans Progressiva (FOP), Demonstrating that Garetosmab Prevents Greater than 99% of Abnormal B
-
Pilavapadin Provides Meaningful Pain Reduction in Adults with Diabetic Peripheral Neuropathic Pain (DPNP) in Data Presented at the European Association for the Study of Diabetes (EASD) and NEUROdiab A
-
X4 Pharmaceuticals Announces Restructuring of Business Operations Designed to Drive Long-Term Value Creation
-
TScan Therapeutics Announces Upcoming Oral and Poster Presentations at the American College of Rheumatology Convergence 2025
-
Axsome Therapeutics Highlights Data Across Its Leading Neuroscience Pipeline at Psych Congress 2025
-
Roivant and Priovant Announce Positive Phase 3 VALOR Study Results for Brepocitinib in 52-Week Placebo-Controlled Trial in Dermatomyositis (DM)
-
Visit Philadelphia, TED Launch International Idea Search for Democracy-Focused TED Talks
-
Positive Phase 3 Results for Denifanstat for the Treatment of Moderate to Severe Acne to be Presented at the EADV Congress 2025 by Partner Ascletis
-
Castle Biosciences Named One of Newsweek’s America’s Greatest Companies 2025
-
Baker Hughes Secures Multi-Year Contract with Petrobras for Offshore Stimulation Vessels
-
AccuStem Sciences and EmeritusDX Expand Blood-Based Testing Capabilities to Advance Cancer Diagnostics and Treatment Planning
-
Pneumagen Launches NeumoBind™ Technology Platform to Unlock New Opportunities in Intranasal Therapeutics
-
ECARX Powers Global Launch of Geely Galaxy M9, Delivering a Next-Generation AI Cockpit Experience
-
Amphista Therapeutics discloses first details of its SMARCA2 degrader program
-
Man Group PLC : Form 8.3 - Spirent Communications Plc
-
YieldMax® ETFs Announces Distributions on ULTY, CONY, FIAT, HOOY, LFGY and Others
-
2025 Emerging Air Economy Development Conference Opens in Wuhu, Anhui Province
-
Form 8.3 - AXA INVESTMENT MANAGERS: Just Group Plc
-
SalMar - Mandatory notification of trade
-
Parsons Awarded Task Order For Indo-Pacific Counter-Nuclear Smuggling System Deployment
